Ke Hu

发表

Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy

D. Ma, Shixuan Wang, Xiaokui Yang, 2005, Journal of Cancer Research and Clinical Oncology.

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway

Weiliang Zhu, Zhijian Xu, Dandan Yu, 2021, Cancer cell international.

Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma

Weiliang Zhu, Gege Chen, Zhijian Xu, 2022, Journal of biomedical science.

In vitro and in vivo metabolism of a novel antimitochondrial cancer metabolism agent, CPI-613, in rats and human

K. Kassahun, V. Reddy, A. Sheldon, 2022 .

A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling

Weiliang Zhu, Wang, Zhijian Xu, 2021 .

A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib.

Weiliang Zhu, Gege Chen, Zhijian Xu, 2020, Cancer letters.

Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple Myeloma

Weiliang Zhu, Zhijian Xu, Jumei Shi, 2020, Journal of Cancer.

Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway.

Weiliang Zhu, Zhijian Xu, Yong Zhang, 2021, Acta biochimica et biophysica Sinica.

MiR-194 suppresses human gastric cancer cell proliferation and induces apoptosis by targeting GGCT

Cong Chen, Ke Hu, Yi Zhang, 2017 .

Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma

Weiliang Zhu, F. Zhan, Gege Chen, 2023, Leukemia.

A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling.

Weiliang Zhu, Zhijian Xu, Jumei Shi, 2021, American journal of translational research.

Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.

Zhijian Xu, Xiaosong Wu, Dongliang Song, 2023, International immunopharmacology.

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway

Gege Chen, Zhijian Xu, Xiaosong Wu, 2023, Journal of Translational Medicine.

TI17, a novel compound, exerts anti‐MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage

Zhijian Xu, Yong Zhang, Xiaosong Wu, 2023, Cancer medicine.

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation

Gege Chen, Zhijian Xu, Xiaosong Wu, 2023, Acta biochimica et biophysica Sinica.

Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma.

Zhijian Xu, Xiaosong Wu, Dongliang Song, 2023, Archives of biochemistry and biophysics.

CD36 Upregulation in HT-29 Tumor Cells Cultured on 3D Multicellular Spheroids Culturing Platform Based on Anisotropic Magnetic Hydrogel.

Cong Chen, Qi Liu, Mengqi Wan, 2018, Journal of biomedical nanotechnology.

EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma

Liangning Hu, Jumei Shi, Ke Hu, 2024, Acta biochimica et biophysica Sinica.